DNLI · Forms 3, 4, 5
Insider trades at Denali Therapeutics Inc.
3 insiders sold $435K of Denali Therapeutics Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Denali Therapeutics Inc. (DNLI) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Peter Scott Chin | Chief Medical Officer | Sell | 1,654 | $22.29 | $37K | Form 4 | |
| Nancy Thornberry | Director | Sell (10b5-1 plan) | 10,824 | $22.85 | $247K | Form 4 | |
| Nancy Thornberry | Director | Sell (10b5-1 plan) | 615 | $23.74 | $15K | Form 4 | |
| Alexander O. Schuth | COFO and Secretary | Sell (10b5-1 plan) | 2,768 | $23.44 | $65K | Form 4 | |
| Ryan J. Watts | President and CEO | Gift | 32,220 | Form 4 | |||
| Alexander O. Schuth | COFO and Secretary | Sell | 2,857 | $25.07 | $72K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.